Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
Cognition
Repeatable Battery for the Assessment of Neuropsychological Status
dementia
neurological disease
progressive supranuclear palsy
Journal
Journal of clinical and experimental neuropsychology
ISSN: 1744-411X
Titre abrégé: J Clin Exp Neuropsychol
Pays: England
ID NLM: 8502170
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
pubmed:
5
2
2019
medline:
21
7
2020
entrez:
5
2
2019
Statut:
ppublish
Résumé
Progressive supranuclear palsy (PSP) is associated with a variety of cognitive deficits, as well as motor and psychiatric disturbances. As clinical trials for PSP evolve, briefer screening instruments will be needed to determine cognitive effects of interventions. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) may fill this gap. Three hundred four participants diagnosed with Richardson's syndrome of PSP were evaluated with the RBANS, as well as other scales typically used in PSP. RBANS performances for these participants fell significantly below expectations for the Total Scale score and all five Indexes. Cognitive scores on the RBANS were also significantly related to other markers of PSP (e.g., motor and functional abilities, depression, global cognition). Compared to other clinical conditions from the literature, patients with PSP show impairment on tests of visuospatial perception and construction and attention. Although additional research is needed, the current study supports the clinical applicability of the RBANS in patients with PSP, as well as its potential for future clinical trials.
Identifiants
pubmed: 30712468
doi: 10.1080/13803395.2019.1572073
pmc: PMC6499681
mid: NIHMS1519087
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
469-475Subventions
Organisme : NIA NIH HHS
ID : K24 AG045333
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG038791
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG063911
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS092089
Pays : United States
Références
J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):313-8
pubmed: 10945805
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
No To Shinkei. 2002 Jun;54(6):463-71
pubmed: 12166095
Arch Clin Neuropsychol. 2003 Jul;18(5):509-20
pubmed: 14591446
Neurocase. 2005 Aug;11(4):268-73
pubmed: 16093227
Neurocase. 2005 Aug;11(4):274-82
pubmed: 16093228
Neuropsychology. 2006 Sep;20(5):558-65
pubmed: 16938018
Brain. 2007 Jun;130(Pt 6):1552-65
pubmed: 17405767
Arch Clin Neuropsychol. 2008 Sep;23(5):603-12
pubmed: 18639437
J Clin Exp Neuropsychol. 2010 Mar;32(3):231-8
pubmed: 19484645
Psychiatry Res. 2010 Apr 30;176(2-3):183-9
pubmed: 20138370
Arch Clin Neuropsychol. 2013 Mar;28(2):104-13
pubmed: 23127882
Gut. 2013 Oct;62(10):1497-504
pubmed: 23297006
Neurology. 2013 Jan 22;80(4):380-4
pubmed: 23303854
Pharmacopsychiatry. 1990 Mar;23(2):94-101
pubmed: 2339182
Psychiatry Res. 2013 Dec 30;210(3):1205-10
pubmed: 24035530
Lancet Neurol. 2014 Jul;13(7):676-85
pubmed: 24873720
Arch Clin Neuropsychol. 2014 Aug;29(5):442-55
pubmed: 24903208
J Clin Exp Neuropsychol. 2014;36(10):1023-30
pubmed: 25363544
Front Behav Neurosci. 2015 Nov 18;9:300
pubmed: 26635554
Parkinsonism Relat Disord. 2016 Jul;28:41-48
pubmed: 27172829
Neurology. 2016 Nov 8;87(19):2016-2025
pubmed: 27742814
Mov Disord. 2017 Jun;32(6):842-852
pubmed: 28436538
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Lancet Neurol. 2017 Jul;16(7):552-563
pubmed: 28653647
Neurology. 2018 Jan 23;90(4):e273-e281
pubmed: 29282336
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
J Neural Transm Suppl. 1994;42:69-78
pubmed: 7964698
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
pubmed: 9845158
J Geriatr Psychiatry Neurol. 1998 Summer;11(2):107-14
pubmed: 9877531